Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche discloses ETA antagonists for circulatory disorders

Aug. 23, 1996

Endothelin ETA inhibitors described by Roche

Aug. 23, 1996

New calcium entry blocker described by Italian researchers

Aug. 23, 1996

Usherdex-4 and other dextrans covered under U.S. patent

Aug. 23, 1996

Forest's Infasurf earns approvable status

Aug. 23, 1996

FR-173657: Fujisawa's bradykinin B2 antagonist

Aug. 23, 1996

PAF antagonist Y-24180 enters phase III

Aug. 23, 1996

Proventil HFA given FDA approval

Aug. 23, 1996

Hoechst Marion Roussel launches Allegra on U.S. market

Aug. 23, 1996

Further nitric oxide synthase inhibitors from Chugai

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...